Literature DB >> 18621971

Pretreatment serum levels of anti-cyclic citrullinated peptide antibodies are associated with the response to methotrexate in recent-onset arthritis.

K Visser, K N Verpoort, H van Dongen, S M van der Kooij, C F Allaart, R E M Toes, T W J Huizinga, A H M van der Helm-van Mil.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18621971     DOI: 10.1136/ard.2008.088070

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  16 in total

1.  Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage.

Authors:  Jing Shi; Rachel Knevel; Parawee Suwannalai; Michael P van der Linden; George M C Janssen; Peter A van Veelen; Nivine E W Levarht; Annette H M van der Helm-van Mil; Anthony Cerami; Tom W J Huizinga; Rene E M Toes; Leendert A Trouw
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-10       Impact factor: 11.205

Review 2.  The pathogenic potential of autoreactive antibodies in rheumatoid arthritis.

Authors:  Marieke Bax; Tom W J Huizinga; René E M Toes
Journal:  Semin Immunopathol       Date:  2014-04-25       Impact factor: 9.623

Review 3.  The influence of ACPA status and characteristics on the course of RA.

Authors:  Annemiek Willemze; Leendert A Trouw; René E M Toes; Tom W J Huizinga
Journal:  Nat Rev Rheumatol       Date:  2012-01-31       Impact factor: 20.543

4.  Serum levels of anti-cyclic citrullinated peptide antibodies are associated with a beneficial response to traditional herbal medicine (Kampo) in rheumatoid arthritis.

Authors:  Toshiaki Kogure; Hiroko Sato; Daijiro Kishi; Tomoyuki Ito; Takeshi Tatsumi
Journal:  Rheumatol Int       Date:  2009-02-22       Impact factor: 2.631

5.  [Biomarkers and personalized medicine].

Authors:  H U Scherer; G-R Burmester; T Häupl
Journal:  Z Rheumatol       Date:  2013-02       Impact factor: 1.372

Review 6.  The role of biomarkers in the management of patients with rheumatoid arthritis.

Authors:  Jackie Nam; Edith Villeneuve; Paul Emery
Journal:  Curr Rheumatol Rep       Date:  2009-10       Impact factor: 4.592

7.  [Personalized medicine in the choice of conventional immunosuppressants and disease modifying antirheumatic drugs].

Authors:  C Fiehn; G Keyßer; H-M Lorenz
Journal:  Z Rheumatol       Date:  2013-02       Impact factor: 1.372

Review 8.  The use of citrullinated peptides and proteins for the diagnosis of rheumatoid arthritis.

Authors:  Ger Jm Pruijn; Allan Wiik; Walther J van Venrooij
Journal:  Arthritis Res Ther       Date:  2010-02-15       Impact factor: 5.156

Review 9.  The advances of methotrexate resistance in rheumatoid arthritis.

Authors:  Jun Yu; Peng Zhou
Journal:  Inflammopharmacology       Date:  2020-08-05       Impact factor: 4.473

Review 10.  cDNA phage display for the discovery of theranostic autoantibodies in rheumatoid arthritis.

Authors:  Patrick Vandormael; Patrick Verschueren; Liesbeth De Winter; Veerle Somers
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.